Michael Lebinski

Michael Lebinski is the host of "Life Finds A Way," a YouTube channel focused on biotech, biology, and science communication. His on-camera work centers on long-form interviews with executives and researchers at clinical-stage biotechnology companies — most prominently the conversation with GT Biopharma's leadership about their TriKE® (Tri-specific Killer Engager) NK-cell (Natural Killer cell — an immune cell that destroys infected or cancerous targets) platform for cancer treatment. That interview, which serves as the sole Pixys video asset for this profile, focuses on immuno-oncology trial design, manufacturing strategy, and the broader case for off-the-shelf NK-cell therapy.

Lebinski's interview style leans technical and educational: he draws out platform-mechanism detail, clinical readouts, and competitive positioning rather than stock-tipping or valuation takes. Episodes on his channel also cover evolutionary biology and broader life-science topics, suggesting a background in or strong familiarity with academic biology alongside his biotech interviews.

The public record on Lebinski outside of YouTube is thin. No commodity, mining, metals, or natural-resource investment activity was surfaced by web research, and the single Pixys video tied to him is unambiguously a biotech discussion. He does not appear to publish a commodities newsletter, manage a resource fund, or produce mining-sector analysis that an investor in gold, silver, copper, uranium, or critical minerals could act on.

For a mining or commodity investor, Lebinski is not a relevant signal source. He is profiled here only because the video ingest picked him up as a host; the channel's subject matter is biotech, not natural resources. If the platform retains him, the honest framing is interviewer-with-limited-commodity-relevance rather than a mischaracterized resource expert.